Our practice continuously performs clinical trials for the world’s top pharmaceutical companies – we pride ourselves in our unparalleled expertise in the use of cosmetic injectable treatments including botulinum toxin and dermal fillers. If you would like to receive information about upcoming trials, please call 561.393.9898
PROTOCOL TITLE |
DATE |
STATUS |
|---|---|---|
| A Randomized, Blinded Evaluator, No-treatment Control, Multicenter, Prospective Clinical Study of RHA® 1 for the Treatment of Moderate to Severe Tissue Volume Deficiencies in the Infraorbital Regions. | March 2022 | Ongoing |
| A Phase II Multi-Center, Prospective, Randomized, Double Blind, Active-Controlled, Single Treatment, Increasing Dose Trial to Study the Safety and Duration of Effect of 40U of PrabotulinumtoxinA-xvfs in Adult Subjects for Treatment of Moderate-to-Severe Glabellar Lines | March 2022 | Ongoing |
| A Phase 3, Multicenter Study to Evaluate the Safety and Efficacy of AGN-151586 for the Treatment of Glabellar Lines | Fab 2022 | Ongoing |
| A Multicenter, Double-Blind, Randomized, Placebo-Controlled Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of OnabotulinumtoxinA X for the Treatment of Moderate to Severe Glabellar Lines | Nov 2021 | Ongoing |
| A double blind, randomized, three-arm, placebo-controlled Phase 2b study to evaluate the efficacy and safety of RZL-012 in subjects seeking submental fat reduction | Nov 2020 | Completed |
| A prospective, randomized, double-blind, placebo-controlled, multicenter study with an open-label extension period to investigate the efficacy and safety of NT 201 in the simultaneous treatment of upper facial lines | Oct 2020 | Completed |
| A Multicenter, evaluator-blinded, randomized, parallel-group, controlled study of the safety and effectiveness of JUVÉDERM VOLUMA® XC injectable gel for correction of temple hollowing | Apr 2020 | Completed |
| Qualitative Interviews for Assessments of Glabellar Lines | Jan 2020 | Completed |
| Qualitative Interviews for Assessments of Temple Hollowing | Jan 2020 | Completed |
| Effects of Alastin Bruise Cream Application to Lower Lid Blepharoplasty Post-Surgical Patients | Dec 2019 | Completed |
| Standalone Validation of the Revised MMPS-P and LFSQ-SA Physical Symptom Items and Development of a Tool to Detect Masseter Muscle Prominence Treatment Candidates | Jul 2020 | Completed |
| Cognitive Interviews for Assessments of Masseter Muscle Prominence | Oct 2019 | Completed |
| A Phase 2a, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Efficacy and Safety of Daxibotulinumtoxin A (DAXI) for Injection for the Treatment of Dynamic Forehead Lines (Frontalis) | Jan 2019 | Completed |
| A Multicenter, Open-Label Study to Evaluate the Safety of QM1114-DP for the Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines | Dec 2019 | Completed |
| A 4-Grade Photonumeric Scale to Evaluate Treatment Effect of Chin Augmentation | Dec 2018 | Completed |
| Evaluation of Safety and Efficacy of AGN-151607 after Single Intramuscular Treatment in Participants with Glabellar Lines | Jun 2018 | Completed |
| A Multi-Phase, Prospective, Multi-Center, Single Blind, Clinical Study to Evaluate the Safety and Efficacy of Allograft Adipose Matrix (AAM) at Full- and Half-Concentration for Pre-Jowl and Malar Augmentation to Correct Age-Related Volume Deficit in the Face, Phase I | Apr 2018 | Completed |
| A Multicenter Single-Blind, Randomized, Controlled Study of the Safety and Effectiveness of Juvederm Volbella XC Injectable Gel for Correction of Infraorbital Hollowing | Sept 2017 | Completed |
| Development of Patient-Reported Outcome Measures in Lower Eyelid Steatoblepharon | Sept 2017 | Completed |
| Qualitative Development of Patient-Reported Outcome Measures in the Jaw Line Area | May 2017 | Completed |
| Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study on the Safety and Pharmacodynamic Response of BOTOX® in Subjects with Moderate to Severe Dynamic Glabellar Lines | Sept 2017 | Completed |
| A Single-center, Randomized, Single-blind, Split-Eye Pilot Study Comparing Alastin’s Regenerating Skin Nectar vs. Standard of Care Pre and Post Upper Blepharoplasty | Jan 2017 | Completed |
| An Open-Label, Multi-Center trial to assess the safety of single and repeat treatments of DaxibotulinumtoxinA for injection for treatment of moderate to severe Glabellar lines | 2016 | Completed |
| A Phase 3, Randomized, Double- Blind, Placebo Controlled, Multi-Center Trial to evaluate the Efficacy and Safety of Daxibotulinumtoxin A for Injection to Treat Moderate to Severe Glabellar Lines | Jul 2016 | Completed |
| A Prospective, Multi-center, Randomized, Evaluator- blinded, Split-hand Study to Evaluate the Effectiveness and Safety of Restylane Lyft with Lidocaine Compared to No Treatment for Injection in the Dorsal Hand to Correct Volume Deficit | Dec 2015 | Completed |
| The Condition of Submental Fullness and Treatment Outcomes Registry (CONTOUR): A Non-Interventional Study of Submental Fullness, Treatment Options Administered, and Associated Outcomes | Oct 2015 | Completed |
| A phase III, multi-center, randomized, double blind, placebo-controlled, single dose, trial to demonstrate the safety and efficacy of DWP-450 in adult subjects for treatment of moderate-to-severe glabellar lines | 2014 | Completed |
| Evaluation of the Safety and Efficacy of Treatment with BOTOX (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects with Forehead and Glabellar Facial Rhytids | 2014 | Completed |
| A Multicenter, Double-blind, Placebo-controlled Safety Study of ATX-101 (Deoxycholic Acid Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects with Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) Grade 1 or CR-SMFRS Grade 4 | Oct 2013 | Completed |
| Bimatoprost in the Treatment of Eyelash Hypertrichosis | Jun 2012 | Completed |
| Long-term Safety and Patient Satisfaction of Effectiveness of Facial Aesthetic Treatment with BOTOX: A 10-Year International Experience | Jun 2012 | Completed |
| A Multicenter, Double-Blind, Randomized, Placebo-controlled, Parallel-group Extension Study to Evaluate the Safety and Efficacy of Botox® (botulinum toxin type A) Purified Neurotoxin Complex in Subjects with Facial Rhytids (Crow’s feet and Glabellar lines) | Jun 2011 | Completed |
| A Prospective, Open Label, Randomized, Crossover Study Evaluating Botox® Cosmetic or Vistabel® for Injection and Juvederm® Injectable Gel for the Treatment of Moderate to Severe Facial Wrinkles and Folds | Dec 2010 | Completed |
| A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Botox® (botulinum toxin type A) Purified Neurotoxin Complex in Subjects with Facial Rhytids (Crow’s feet and Glabellar Lines) | Nov 2010 | Completed |
| A Prospective, Open-Label, Randomized, Comparative, Split-Face Study Evaluating Reconstituted Juvederm® Ultra Injectable Gel (17mg./mL.) versus CosmoDerm®I Human-Based Collagen Implant for the Treatment of Vertical Lip Rhytids and Radial Cheek Lines | Sept 2010 | Completed |
| A Non-interventional Observational and Medical Record Review of Patient Outcomes with Bimatoprost Ophthalmic Solution 0.03% (Latisse®) for the Treatment of Hypotrichosis of the Eyelashes | May 2010 | Completed |
| Assessing Immediate Changes in the Appearance of Fine Lines/Wrinkles after use of a Clarisonic Opal and Pro RT Serum. Sponsored by Pacific Bioscience Laboratory | May 2010 | Completed |
| A One Year, Multicenter, Double-Masked, Randomized, Parallel-Group Study Assessing the Safety and Efficacy of Once Daily Application of Bimatoprost 0.03% Solution Compared to Vehicle to Treat Hypotrichosis of the Eyelashes from Varied Etiologies | Nov 2009 | Completed |
| A Pivotal USA Randomized, Evaluator-Blinded, Active-Controlled, Multi-Center, Split-Face Comparison Study of LSIR Versus Juvederm Ultra in the Treatment of Moderate to Severe Facial Wrinkles and Folds | Dec 2009 | Completed |
| A Multi-Center, Open Label Feasibility Study of the Safety and Effectiveness of Juvederm Ultra Gel in Subjects who desire Lip Enhancement | Aug 2007 - Aug 2008 | Completed |
| A Phase III, Multicenter, Open-Label, Extension Study to Assess the Long-Term Safety of Repeat Administration of Reloxin in the Treatment of Glabellar Lines | May 2007 - Sept 2009 | Completed |
| A Multicenter, Double-Masked, Randomized, Parallel Study Assessing the Safety and Efficacy of Once-Daily Application of Bimatoprost Solution Compared to Vehicle in Increasing Overall Eyelash Prominence | May 2007 – May 2008 | Completed |
| Comparative Effectiveness and Safety of Juvederm Ultra Gel vs. Restylane in Lip Augmentation | Jan 2007 – Dec 2008 | Completed |
| A Phase III, Randomized, Placebo-Controlled, Multi-Center, Double-Blind Study of the Safety and Duration of Efficacy of Reloxin (Botulinum Type A Toxin) in Correction of Moderate to Severe Glabellar Lines | Nov 2006 | Completed |
| A Continued Access Study of Mentor’s CX002; Dermal Filler Medical Device, when applied as an Intra-Dermal Implant for the Correction of Facial Wrinkles | Oct 2006 – Oct 2007 | Completed |
| Evaluation of Purogen for Soft Tissue Augmentation of the Nasolabial Folds. Federal Drug Administration Continued Access Study | Oct 2005 – Oct 2006 | Completed |
| A Placebo Controlled Study to Assess Patient-Reported Outcomes in Subjects Receiving BOTOX (Botulinum Toxin Type A) for the Treatment of Moderate to Severe Glabellar Rhytids | Jan 2005 – Jan 2006 | Completed |
| A Randomized Study of the Safety and Effectiveness of DL6049 (injectable poly-L-lactic acid Versus CosmoPlast Collagen Implant in the Treatment of Nasolabial Fold Wrinkles | 2003 -2006 | Completed |
| A Randomized Study of the Safety and Efficacy of CTA (injectable hyaluronic acid) Versus Cosmoplast Implant in the Treatment of Nasolabial Folds | 2003 | Completed |
| Evaluation of the Safety and Efficacy of Restylane for Lip Augmentation | 2002 - 2003 | Completed |
| Evaluation of Botulinum Toxin Type A (Botox) for the treatment of Lip Rhytids and for Lip Augmentation. Protocol development and clinical study | 2002 - 2003 | Completed |